Virtus ETF Advisers LLC Krystal Biotech, Inc. Transaction History

Virtus ETF Advisers LLC

  • $196 Million
  • Q2 2024

A detailed history of Virtus ETF Advisers LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,802 shares of KRYS stock, worth $318,755. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,802
Previous 744 142.2%
Holding current value
$318,755
Previous $132,000 150.0%
% of portfolio
0.17%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$153.12 - $183.64 $162,000 - $194,291
1,058 Added 142.2%
1,802 $330,000
Q1 2024

May 15, 2024
SELL
$108.01 - $179.35 $5,616 - $9,326
-52 Reduced 6.53%
744 $132,000
Q4 2023

Feb 15, 2024
BUY
$96.0 - $128.29 $2,880 - $3,848
30 Added 3.92%
796 $98,000
Q3 2023

Nov 07, 2023
SELL
$108.51 - $130.22 $8,029 - $9,636
-74 Reduced 8.81%
766 $88,000
Q2 2023

Aug 14, 2023
SELL
$78.48 - $130.32 $36,571 - $60,729
-466 Reduced 35.68%
840 $98,000
Q1 2023

May 15, 2023
SELL
$72.39 - $84.27 $36,050 - $41,966
-498 Reduced 27.61%
1,306 $104,000
Q4 2022

Feb 14, 2023
SELL
$63.14 - $79.9 $16,858 - $21,333
-267 Reduced 12.89%
1,804 $142,000
Q3 2022

Nov 14, 2022
BUY
$64.85 - $82.4 $1,037 - $1,318
16 Added 0.78%
2,071 $144,000
Q2 2022

Aug 12, 2022
SELL
$48.93 - $73.47 $7,045 - $10,579
-144 Reduced 6.55%
2,055 $135,000
Q1 2022

May 16, 2022
SELL
$51.99 - $72.11 $7,122 - $9,879
-137 Reduced 5.86%
2,199 $146,000
Q4 2021

Feb 14, 2022
SELL
$39.81 - $88.24 $37,899 - $84,004
-952 Reduced 28.95%
2,336 $163,000
Q3 2021

Nov 15, 2021
SELL
$52.01 - $71.77 $8,685 - $11,985
-167 Reduced 4.83%
3,288 $172,000
Q2 2021

Aug 10, 2021
SELL
$62.14 - $81.82 $105,389 - $138,766
-1,696 Reduced 32.93%
3,455 $235,000
Q1 2021

May 17, 2021
BUY
$59.42 - $85.46 $5,882 - $8,460
99 Added 1.96%
5,151 $397,000
Q4 2020

Feb 12, 2021
SELL
$40.64 - $61.38 $72,908 - $110,115
-1,794 Reduced 26.21%
5,052 $303,000
Q3 2020

Nov 13, 2020
SELL
$37.76 - $48.49 $35,418 - $45,483
-938 Reduced 12.05%
6,846 $295,000
Q2 2020

Aug 05, 2020
BUY
$37.03 - $60.0 $83,984 - $136,080
2,268 Added 41.12%
7,784 $322,000
Q1 2020

May 14, 2020
SELL
$35.02 - $65.64 $27,700 - $51,921
-791 Reduced 12.54%
5,516 $239,000
Q4 2019

Feb 13, 2020
SELL
$33.17 - $65.23 $98,713 - $194,124
-2,976 Reduced 32.06%
6,307 $349,000
Q3 2019

Nov 12, 2019
SELL
$34.72 - $51.3 $17,950 - $26,522
-517 Reduced 5.28%
9,283 $322,000
Q2 2019

Aug 13, 2019
BUY
$27.2 - $41.2 $266,560 - $403,760
9,800 New
9,800 $395,000

Others Institutions Holding KRYS

# of Institutions
275
Shares Held
24.9M
Call Options Held
270K
Put Options Held
172K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.54B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email